Abstract
We describe what we believe is the first psychiatric hospitalization due to GHB-induced delirium reported in the medical literature. We examine the use of the substance gamma hydroxybutyric acid (GHB) and describe the clinical findings in a patient who presented to an acute inpatient psychiatric unit with a chief complaint of feeling suicidal and a 1-year history of GHB use. A review of the literature and GHB's availability through the Internet are discussed.
MeSH terms
-
Adjuvants, Anesthesia* / adverse effects
-
Adult
-
Delirium / chemically induced*
-
Delirium / diagnosis
-
Delirium / rehabilitation
-
Female
-
Hallucinations / chemically induced
-
Hallucinations / diagnosis
-
Hallucinations / rehabilitation
-
Humans
-
Mental Status Schedule
-
Psychoses, Substance-Induced / diagnosis
-
Psychoses, Substance-Induced / psychology
-
Psychoses, Substance-Induced / rehabilitation
-
Sodium Oxybate* / adverse effects
-
Substance Withdrawal Syndrome / diagnosis
-
Substance Withdrawal Syndrome / psychology
-
Substance Withdrawal Syndrome / rehabilitation
-
Substance-Related Disorders / diagnosis*
-
Substance-Related Disorders / psychology
-
Substance-Related Disorders / rehabilitation
-
Suicide / psychology
-
Suicide Prevention
Substances
-
Adjuvants, Anesthesia
-
Sodium Oxybate